The solubility behavior of drugs remains one of the most exigent aspects in formulation development. With the advent of combinatorial chemistry and high throughput screening, the number of poorly water soluble compounds has dramatically increased. Among all the newly discovered chemical entities, about 40-45% drugs fail to reach market due to their poor water solubility. Because of solubility problem, bioavailability of drugs gets affected and hence solubility enhancement becomes necessary. Solid dispersions have attracted considerable interest as an efficient means of improving the dissolution rate and hence the bioavailability of drugs. Therefore, the application of this technique proves to be an important stratagem for pharmaceutical companies. However, the in -depth knowledge of the solid dispersion is desired for the scale up of formulation, from laboratory scale to industrial scale. There are various methods available to improve the solubility of the new drug in which solid dispersion emerged promising. A Solid dispersion generally composed of two components-the drug and the polymer matrix. Hence, this approach is expected to form a basis for the commercialization of many poorly water-soluble and water-insoluble drugs in their solid-dispersion formulations in the near future. This article reviews the various preparation techniques, carriers used, advantages and limitations of solid dispersions and compiles some of the recent advances.
INTRODUCTION
Solubility is a significant physicochemical factor affecting absorption of drug and its therapeutic effectiveness. Formulation development would lead to be failure if drug having poor aqueous solubility. The venture to improve the solubility and dissolution of hydrophobic drugs remain one of the dificult tasks in drug development. Several methods have been introduced to triumph over this problem.
1 , 2 Various methods to increase the solubility of drugs are available such as solid dispersion, self emulsifying drug delivery, Liquisolid techniques etc, in which drug in solution state or dissolved drug is adsorbed over insoluble carriers [3] [4] [5] [6] Model list of Essential Medicines of the World Health Organization (WHO) has assigned BCS (Biopharmaceutics Classification System) classification on the basis of data available in the public domain. Out of 130 orally administered drugs on the WHO list, 61 could be classified with certainty.
84% of these drugs belong to class I (highly soluble, highly permeable) 17% to class II (poorly soluble, highly permeable) 39% to class III (highly soluble, poorly permeable) and 10% to class IV (poorly soluble, poorly permeable)
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The term solid dispersion refers to a group of solid products consisting of at least two different components, a hydrophilic matrix and a hydrophobic drug. The drug can be dispersed molecularly, in amorphous particles (clusters) or in crystalline particles
7
. Pharmaceutical polymers are used to create this matrix and their selection is based on many factors, including physicochemi8al (e.g. drug-polymer miscibility and stability) and pharmacokinetic (e.g. rate of absorption) constraints 8 . Fig. 1 categorizes various possible categories of solid dispersions. The solid-dispersion components consist mainly of active pharmaceutical ingredients (API), the polymer, plasticizers, stabilizers, and other agents.
Solid dispersion systems can increase dissolution rate and bioavailability of water insoluble drugs as when these are exposed to aqueous media, the carrier dissolves, and the drug is released as very fine colloidal particles. This greatly reduces particle size and increases surface area, which results in improved dissolution rates and per oral absorption. Furthermore, no energy is required to break up the crystal lattice of a drug during the dissolution process. Drug solubility and wettability may be increased by surrounding hydrophilic carriers 9, 10 This approach has been used for a variety of poorly soluble drugs such as nimesulide, ketoprofen, tenoxicam, nifedipine, nimodipine, ursodeoxycholic acid, carbamazepine, celecoxib, carvedilol 5 and albendazole.
11

Advantages of Solid Dispersion
Solid dispersions are obtained by separate technological processes that are to disperse pharmacologically active component in a carrier or matrix in the solid state, in order to improve the solubility and increase the rate of dissolution, which, in turn, modulates the therapeutic action due to increased bioavailability 4, 12, 13 . They have also been used to increase the chemical stability of drugs in solution or suspension 14. The first generation of SD was prepared employing crystalline carriers. These carriers include sugars and urea, which have in SD disadvantages crystal formation, which, being thermodynamically more stable, they do not release the drug with the desired speed 15 .
Solid dispersions can be used as formulation vehicle to facilitate the preclinical safety and early clinical studies on new chemical entities with very low aqueous solubility. It provides a means to rapidly assess the safety and efficacy profile of the drug substance that may be otherwise difficult to obtain.
Disadvantages of Solid Dispersion
2, 4,16
Moreover, most of the polymers used in solid dispersions can absorb moisture, which may result in phase separation, crystal growth or conversion from the amorphous to the crystalline state or from a metastable crystalline form to a more stable structure during storage. This may result in decreased solubility and dissolution rate. demerits of solid dispersions is their poor scale-up for the purposes of manufacturing.
MECHANISM OF SOLID DISPERSION
The formulations of solid dispersions results into reduction in particle size, improved wettability and enhancement of the dispersibility of the drug, thereby markedly improving the dissolution rate. The suggested mechanism behind this tremendous increase in dissolution rate may include: 
TYPES OF SOLID DISPERSIONS Eutectic mixtures
18, 19
A simple eutectic mixture consists of two compounds which are completely miscible in the liquid state but only to a very limited extent in the solid state. It is prepared by rapid solidification of fused melt of two components that show complete liquid miscibility but negligible solid-solid solution
Amorphous precipitation in crystalline matrix
20, 21
This is similar to simple eutectic mixtures but only difference is that drug is precipitated out in an amorphous form.
Solid solution 22
Solid solutions are comparable to liquid solutions, consisting of just one phase irrespective of the number of components. In the case of solid solutions, the drug's particle size has been reduced to its absolute minimum viz. the molecular dimensions and the dissolution rate is determined by the dissolution rate of the carrier. Classified according to their miscibility (continuous versus discontinuous solid solutions) or second, according to the way in which the solvate molecules are distributed in the solvendum (substitutional, interstitial or amorphous).
Continuous solid solutions
In a continuous solid solution, the components are miscible in all proportions. Theoretically, this means that the bonding strength between the two components is stronger than the bonding strength between the molecules of each of the individual components. Solid solutions of this type have not been reported in the pharmaceutical world till date.
Discontinuous solid solutions 22
In the case of discontinuous solid solutions, the solubility of each of the components in the other component is limited. Due to practical considerations, it has been suggested by Goldberg et `solid solution' should only be applied when the mutual solubility of the two components exceeds 5%.
Substitutional solid dispersions 23
Substitution is only possible when the size of the solute molecules differs by less than 15% or so from that of the solvent molecules. Classical solid solutions have a crystalline structure, in which the solute molecules can either substitute for solvent molecules in the crystal lattice or fit into the interstices between the solvent molecules.
Interstitial solid solutions 24, 25
In interstitial solid solutions, the dissolved molecules occupy the interstitial spaces between the solvent molecules in the crystal lattice. Solute molecule diameter should be less than 0.59 times than that of solvent molecular diameter. 
METHODS OF SOLID DISPERSION
Various methods have been developed for preparation of solid dispersions, these methods deal with the challenge of mixing a matrix and a drug, preferably on a molecular level, while matrix and drug are generally poorly miscible. During many of the preparation techniques, demixing (partially or complete), and formation of different phases is observed. Phase separations like crystallization or formation of amorphous drug clusters are difficult to control and therefore unwanted.
The brief description of the methods is as follows:
Kneading Method
In this method, the polymer and drug are mixed by geometric dilution. The mixture is malaxada with adding the amount of solvent minina (equivalent to 30% of the post of weight) in order to obtain a moist consistency. Industrially, a mixture of components is performed in a malaxadora, and in this case, required some adjustments in the methodology used, initially at the level bench, which can cause some modifications of the physical and chemical characteristics and pharmacotechnical the product. The drying of the material can be done in an oven or directly in malaxadora followed by pulverization to standardize the size particle. Due to the simplicity, the high throughput and the scale transposition facility, this method is the most widely used in the pharmaceutical industry 26 .
Solvent melting method
Accurately weighed drug is dissolved in organic solvent. The solution is incorporated into the melt of mannitol and cooled suddenly and mass is kept in desiccator for complete drying. The solidified mass is crushed, pulverized and passed through sieve. This technique possesses unique advantages of both the fusion and solvent evaporation methods. From a practical standpoint, it is only limited to drugs with a low therapeutic dose (less than 50 mg).
27
Spray-Drying Method
Drug is dissolved in suitable solvent and the required amount of carrier is dissolved in water. Solutions are then mixed by sonication or other suitable method to produce a clear solution, which is then spray dried using spray dryer.
28
Method supercritical fluid
The process of supercritical fluid has emerged as an alternative method to the solvent method, forming small particle size precipitation and low organic matter content, with also better flow. Powder flowability is important when commercialization of the process is desired 35 . Carbon dioxide is currently We used this technique due to the advantages associated with its use, as a non -toxic gas, non -flammable, inexpensive and low critical temperature, making it attractive in the processing of heat sensitive drugs and the process solvent removal extremely controlled 13 . Although the results promising described in the literature, is a
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Co-grinding method
Physical mixture of drug and carrier is mixed for some time employing a blender at a particular speed. The mixture is then charged into the chamber of a vibration ball mill steel balls are added. The powder mixture is pulverized. Then the sample is collected and kept at room temperature in a screw capped glass vial until use. Ex. chlordiazepoxide and mannitol solid dispersion was prepared by this method.
Gel entrapment technique
Hydroxyl propyl methyl cellulose is dissolved in organic solvent to form a clear and transparent gel. Then drug for example is dissolved in gel by sonication for few minutes. Organic solvent is evaporated under vacuum. Solid dispersions are reduced in size by mortar and sieved.
31
Melting /Fusion method
This process involves the formulation of physical mixture of a active ingredients and a water soluble carrier and heating it directly until it melted. The melted mixture is then solidified rapidly in an ice-bath under vigorous stirring. The final solid mass is crushed, pulverized and sieved. The modification in the method can be done by pouring the homogenous melt in the form of a thin layer onto a ferrite plate or a stainless steel plate and cooled by flowing air or water on the opposite side of the plate. In addition, a super-saturation of a solute or drug in a system can often be obtained by quenching the melt rapidly from a high temperature. Under such conditions, the solute molecule is arrested in the solvent matrix by the instantaneous solidification process. The quenching technique gives a much finer dispersion of crystallites when used for simple eutectic mixtures 32, 33 . Advantage of melting method is that it is economic and solventless process, however this method is not suitable for the drug or carrier which is unstable at fusion temperature or evaporates at higher temperature.
Solvent evaporation method
In this method, the physical mixture of the drug and carrier is dissolved in a common solvent, which is evaporated until a clear, solvent free film is left. The film is further dried to constant weight. The main advantage of the solvent method is thermal decomposition of drugs or carriers can be prevented because of the relatively low temperatures required for the evaporation of organic solvents 34 . 
CHARACTERIZATION OF SOLID DISPERSIONS
Amorphous content:
This study performed by the DSC, Powder X-ray diffraction, Polarised light optical microscopy and Hot stage microscopy Dissolution enhancement 37 :
Solubility enhancement by the solid dispersion was examined by help of following parameters; 
Stability:
Stability of the solid dispersion was studied by Isothermal Calorimetry, DSC (Tg, Temperature recrystallization) and Saturated solubility studies
Water vapour sorption
Water vapour sorption can be used to discriminate between amorphous and crystalline material when the hygroscopicity is different. This method requires accurate data on the hygroscopicity of both completely crystalline and completely amorphous samples.
39
Isothermal Microcalorimetry
Isothermal microcalorimetry measures the crystallization energy of amorphous material that is heated above its glass transition temperature (Tg) . This technique has some limitations. Firstly, this technique can only be applied if the physical stability is such that only during the measurement crystallization takes place. Secondly, it has to be assumed that all amorphous material crystallizes.
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APPLICATIONS OF SOLID DISPERSION 41, 42
Solid dispersion systems can provide numerous additional benefits; some of them are as follows:
1. To increase the solubility of poorly soluble drugs thereby increase the dissolution rate, absorption and bioavailability.
2. To stabilize unstable drugs against hydrolysis, oxidation, recrimination, isomerization, photo-oxidation and other decomposition procedures.
3. To reduce a side effect of certain drugs.
4. Masking of unpleasant taste and smell of drugs.
5. Improvement of drug release from ointment creams and gels.
6. To avoid undesirable incompatibilities.
7. To obtain a homogeneous distribution of a small amount of drug in solid state.
8. To dispense liquid (up to 10%) or gaseous compounds in a solid dosage.
9. To formulate a fast release primary dose in a sustained released dosage form.
10. To formulate sustained release regimen of soluble drugs by using poorly soluble or insoluble carriers.
11. To reduce pre-systemic inactivation of drugs like morphine and progesterone
CONCLUSION
The enhancement solubility of poorly water soluble drugs remains one of the most challenging aspects of drug development. Solubilization of drug is the rate determining step for oral absorption of drugs, which can subsequently affect the in vivo absorption of drug.
Because of solubility problem of many drugs the bioavailability of these gets affected and hence solubility enhancement becomes necessary. Solid dispersions are one of the most attractive processes to improve drug's poor water solubility. Various solubility enhancers like water-soluble carriers, co solvents, surfactants and superdisintegrants via solid dispersion approach (fusion method and solvent evaporation method) aids in solubility enhancement. These significantly help to improve the bioavailability and bioequivalence
